ISSN: 2149-2247 | E-ISSN: 2149-2549
Volume : 44 Issue : 6 Year : 2022
Update on COVID-19 Co-infection [Erciyes Med J]
Erciyes Med J. 2022; 44(6): 540-543 | DOI: 10.14744/etd.2022.77864

Update on COVID-19 Co-infection

Elif Şeker1, Öner Özdemir2
1Department of Pediatrics, Sakarya University, Training and Research Hospital, Sakarya, Türkiye
2Division of Allergy and Immunology, Department of Pediatrics, Sakarya University, Training and Research Hospital, Sakarya, Türkiye

World Health Organization data indicate that as of April 2022, 6.2 million deaths have been reported worldwide due to coronavirus disease 2019 (COVID-19). In Türkiye, official statistics indicate some 15 million cases and a death toll of 98,660. It is important that clinicians consider the possibility of the co-occurrence of other respiratory microorganisms with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the virus that causes COVID-19, when managing treatment, particularly severe COVID-19 patients. The burden and effect of a secondary infection may be significant, especially in patients with chronic disease and advanced age. Proper attention to potential co-infections can prevent COVID-19 progression and the development of complications.

Keywords: Coronavirus, co-infection, COVID-19, pandemic, SARS-CoV-2.

Elif Şeker, Öner Özdemir. Update on COVID-19 Co-infection. Erciyes Med J. 2022; 44(6): 540-543

Corresponding Author: Elif Şeker, Türkiye
Manuscript Language: English
LookUs & Online Makale